Elicio Therapeutics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $-81.4M | $73.0M |
| Jun 2022 | — | $-88.6M | $598.0K |
| Sep 2022 | — | $-95.7M | $1.8M |
| Dec 2022 | — | $-102.1M | $6.2M |
| Mar 2023 | — | $-109.9M | $8.6M |
| Jun 2023 | — | $23.6M | $21.7M |
| Sep 2023 | — | $13.3M | $14.8M |
| Dec 2023 | — | $11.4M | $12.9M |
| Mar 2024 | — | $4.9M | $11.9M |
| Jun 2024 | — | $-1.7M | $3.4M |
| Sep 2024 | — | $-19.0M | $26.0M |
| Dec 2024 | $20.0M | $-11.3M | $17.6M |
| Mar 2025 | — | $8.9M | $18.4M |
| Jun 2025 | $9.3M | $1.8M | $22.1M |
| Sep 2025 | $9.7M | $3.8M | $20.6M |
| Dec 2025 | $9.4M | $1.6M | $18.6M |
| Mar 2026 | $9.5M | $-1.4M | $14.9M |
| Jun 2026 | $9.5M | $7.9M | $23.5M |